Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:29 PM
Ignite Modification Date:
2025-12-24 @ 3:29 PM
NCT ID:
NCT04525092
Eligibility Criteria:
Inclusion Criteria:
* Hospitalised in the ICU
* Acute kidney injury stage 3 (KDIGO-AKI Criteria)
* Requiring RRT for AKI, as judged by the attending clinician (initiation) or conversion from CRRT to intermittent dialysis
* Adult of 18 years or more
Exclusion Criteria:
* Female subjects who are pregnant or breast-feeding or considering becoming pregnant during the study.
* Subjects who are participating in another study involving dialysis interventions
* Subjects or relatives/next-of-kin unable to provide written informed consent
* Creatinine clearance (CrCl) \< 30 mL/min measured by 24-hour urine collection or eGFR or on chronic dialysis at baseline
* Subjects on active immunosuppressive therapy (\>10mg of prednisone, biologic therapies, calcineurin inhibitors, mTOR inhibitors or antimetabolites)
* Subjects with active contraindication to anticoagulation during dialysis session
* Subjects whose RRT is not part of their life goal
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04525092
Study Brief:
Protocol Section:
NCT04525092